(S)-BoroLeu-(-)-Pinanediol-CF3COOH CAS 477254-69-6 Ubumsulwa ≥97.0% Ukungcola kwe-Bortezomib 37 Trifluoroacetate High Purity

Incazelo emfushane:

Igama Lekhemikhali: (S)-BoroLeu-(-)-Pinanediol-CF3COOH

Amazwi afanayo: I-Bortezomib Impurity 37 Trifluoroacetate

I-CAS: 477254-69-6

Ukubukeka: I-Crystalline Powder Emhlophe ukuya Kokumhlophe

Ubumsulwa: ≥97.0%

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

E-mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Nikeza Ngokuhlanzeka Okuphezulu kanye Nekhwalithi Ezinzile
Igama Lekhemikhali: (S)-BoroLeu-(-)-Pinanediol-CF3COOH
I-CAS: 477254-69-6
Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Chemical Properties:

Igama Lekhemikhali (S)-BoroLeu-(-)-Pinanediol-CF3COOH
Omqondofana I-Bortezomib Ukungcola 37 Trifluoroacetate;(S)-BoroLeu-(+)-Pinanediol-Trifluoroacetate
Inombolo ye-CAS 477254-69-6
Inombolo yeCAT I-RF-PI265
Isimo Sesitoko Kukhona kusitoki
I-Molecular Formula I-C17H29BF3NO4
Isisindo samangqamuzana 379.23
Isimo Sokuthumela Kuthunyelwe Ngaphansi Kwezinga Lokushisa Le-Ambient
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka I-Crystalline Powder emhlophe ukuya kokumhlophe
Ubumsulwa ≥97.0%
Izinsimbi Ezisindayo ≤20ppm
Ukulahlekelwa Ekumisweni ≤3.0%
Izinsalela ekushiseni ≤ 0.20%
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Bortezomib Ukungcola 37 Trifluoroacetate

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, i-Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo nomnikezeli we-(S)-BoroLeu-(-)-Pinanediol-CF3COOH (CAS: 477254-69-6) enekhwalithi ephezulu.

(S)-BoroLeu-(-)-Pinanediol-CF3COOH (CAS: 477254-69-6) ukungcola kwe-Bortezomib (CAS 179324-69-7), ebizwa nangokuthi i-Bortezomib Ukungcola 37 Trifluoroacetate.I-Bortezomib (i-CAS 179324-69-7) ekwelapheni i-Multiple Myeloma.I-Bortezomib ivunyelwe ukusetshenziswa kwezokwelapha e-United States ku-2003 nase-European Union ku-2004.

Bhala umyalezo wakho lapha futhi usithumelele wona